Amylyx Pharmaceuticals, Inc. (AMLX)
27.79
-2.50
(-8.25%)
USD |
NASDAQ |
Nov 16, 16:00
27.79
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Total Liabilities (Quarterly) : 33.06M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 33.06M |
| June 30, 2026 | 25.40M |
| March 31, 2026 | 20.44M |
| December 31, 2025 | 28.82M |
| September 30, 2025 | 30.74M |
| June 30, 2025 | 26.72M |
| March 31, 2025 | 18.26M |
| December 31, 2024 | 28.87M |
| September 30, 2024 | 54.51M |
| June 30, 2024 | 70.85M |
| March 31, 2024 | 93.02M |
| December 31, 2023 | 84.02M |
| September 30, 2023 | 48.18M |
| Date | Value |
|---|---|
| June 30, 2023 | 67.22M |
| March 31, 2023 | 55.31M |
| December 31, 2022 | 50.85M |
| September 30, 2022 | 37.42M |
| June 30, 2022 | 32.45M |
| March 31, 2022 | 33.49M |
| December 31, 2021 | 17.43M |
| September 30, 2021 | 15.18M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 8.767M |
| September 30, 2020 | 0.00 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.24B |
| ANI Pharmaceuticals, Inc. | 930.55M |
| Corcept Therapeutics, Inc. | 200.29M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 115.90B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 786.80M |
| Shareholders Equity (Quarterly) | 753.74M |
| Debt to Equity Ratio | 0.0066 |
| Current Ratio | 26.81 |
| Net Debt Paydown Yield | 0.01% |